{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:52:49Z","timestamp":1792687969999,"version":"4.5.0"},"reference-count":32,"publisher":"American Chemical Society (ACS)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2017,9,28]]},"DOI":"10.1021\/acs.jmedchem.7b00846","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T17:26:07Z","timestamp":1501262767000},"page":"7810-7819","source":"Crossref","is-referenced-by-count":122,"title":["Neuroactive Steroids. 2. 3\u03b1-Hydroxy-3\u03b2-methyl-21-(4-cyano-1\n                    <i>H<\/i>\n                    -pyrazol-1\u2032-yl)-19-nor-5\u03b2-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (\u03b3-Aminobutyric Acid)\n                    <sub>A<\/sub>\n                    Receptor"],"prefix":"10.1021","volume":"60","author":[{"given":"Gabriel","family":"Martinez Botella","sequence":"first","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1172-7064","authenticated-orcid":true,"given":"Francesco G.","family":"Salituro","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyd L.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Beresis","sequence":"additional","affiliation":[{"name":"Shanghai Chempartner, 998 Halei Road, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Bai","sequence":"additional","affiliation":[{"name":"WuXi AppTec, 288 Fute Zhong Road, Shanghai 200131, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4333-365X","authenticated-orcid":true,"given":"Maria-Jesus","family":"Blanco","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel M.","family":"Belfort","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dai","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Loya","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Ackley","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L.","family":"Althaus","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Grossman","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Doherty","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Robichaud","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-800167-7.00003-1"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2422758"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1038\/nature05324"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2007.03.011"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.10.003"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3340-09.2009"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1403285111"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12289"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3426-07.2008"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1124\/mol.51.5.833"},{"key":"ref11\/cit11","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0021-9258(18)45961-3","volume":"267","author":"Wieland H.","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1042\/bst0320553"},{"key":"ref13\/cit13","unstructured":"Vaitkevicius, H.; Ng, M. C.; Moura, L.; Rosenthal, E. S.; Westover, M. B.; Rosand, J.; Rogawski, M. A.; Reddy, K.; Cole, A. J.Successful allopregnanolone treatment of new onset refractory status epilepticus (NORSE): First in man experience. InThe 4th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures; Salzburg, Austria, April 4\u20136, 2013; 2013; p124(abstract P29)."},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2015.01.001"},{"key":"ref15\/cit15","unstructured":"A Study With SAGE-547 for Super-Refractory Status Epilepticus;ClinicalTrials.gov;U.S. National Institutes of Health:Bethesda, MD, 2015; https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT02477618?term=sage+therapeutics&rank=6(Accessed April 10, 2017)."},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2576"},{"issue":"16","key":"ref17\/cit17","doi-asserted-by":"crossref","first-page":"P4.297","DOI":"10.1212\/WNL.86.16_supplement.P4.297","volume":"86","author":"Ellenbogen A.","year":"2016","journal-title":"Neurology"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001362"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2010.120"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2012.10.005"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00032"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2017.05.001"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13634"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)89058-6"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1021\/ja00301a048"},{"key":"ref26\/cit26","unstructured":"Martinez Botella, G.; Harrison, B. L.; Robichaud, A. J.; Salituro, F. G.; Beresis, R. T.19-Nor-C3,3-disubstituted C21-\n                      N\n                      -Pyrazolyl Steroids as GABA Receptor Modulators and their Preparation. WO2014169833, 2014."},{"key":"ref27\/cit27","unstructured":"Martinez Botella, G.; Harrison, B. L.; Robichaud, A. J.; Salituro, F. G.; Beresis, R. T.Neuroactive Steroids in Treatment of CNS-related Diseases and their Preparation. WO2015180679, 2015."},{"key":"ref28\/cit28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-5347(25)00374-X","volume":"240","author":"Gee K. W.","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2015.01.001"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2003.10.007"},{"key":"ref33\/cit33","unstructured":"Althaus, A. L.; Belfort, G. M.; Hammond, R. S.; Ackley, M. A.; Quirk, M. C.; Martinez Botella, G.; Salituro, F. G.; Robichaud, A. J.; Doherty, J. J.Unpublished results."},{"key":"ref34\/cit34","unstructured":"SAGE217.ClinicalTrials.gov;U.S. National Institutes of Health:Bethesda, MD, 2017; https:\/\/clinicaltrials.gov\/ct2\/results?term=SAGE217&Search=Search&view=record(Accessed April 10, 2017)."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.7b00846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T14:42:39Z","timestamp":1750776159000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.7b00846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":32,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,9,28]]}},"alternative-id":["10.1021\/acs.jmedchem.7b00846"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00846","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727847766.793560292","asserted-by":"object"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]}}}